Stocktoria
Cadre Holdings, Inc. CDRE
Cadre Holdings, Inc. (CDRE) earns a Piotroski F-score of 6/9 (mixed financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 1.29% (safety: safe). FY2025 revenue was $610.3M at a 7.2% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -2.47 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 6/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.339 |
| Retained earnings / assets | 0.045 |
| EBIT / assets | 0.087 |
| Equity / liabilities | 0.703 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| CDRE | Cadre Holdings, Inc. | 6/9 | 3.7 | 27.2 | +7.5% |
| AVNS | AVANOS MEDICAL, INC. | 5/9 | 1.17 | — | +1.9% |
| INGN | Inogen Inc | 4/9 | 2.26 | — | +3.9% |
| ESTA | ESTABLISHMENT LABS HOLDINGS INC. | 4/9 | -2.1 | — | +27.1% |
| LAKE | LAKELAND INDUSTRIES INC | 2/9 | 4.56 | — | +15.2% |
| SMTI | Sanara MedTech Inc. | 4/9 | -1.26 | — | +19% |
| APT | ALPHA PRO TECH LTD | 4/9 | 12.4 | 16.1 | +2.3% |
About Cadre Holdings, Inc.
Cadre Holdings, Inc. manufactures and distributes safety equipment and other related products that provides protection to users in hazardous or life-threatening situations in the United States and internationally. It operates through two segments, Product and Distribution. The company offers body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brand names; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products. It also provides third-party products, such as uniforms, optics, boots, firearms, and ammunition. In addition, the company designs, manufactures and services equipment, vessels, precision components and remote handling systems for the nuclear, defence, and oil and gas industries. It serves first responders, such as state and local law enforcement, fire and rescue, explosive ordnance disposal technicians, emergency medical technicians, fishing, and wildlife enforcement and departments of corrections, as well as federal agencies, including the U.S. Department of State, U.S. Department of Defense, U.S. Department of Interior, U.S. Department of Justice, U.S. Department of Homeland Security, U.S. Department of Corrections, the Department of Energy, and various foreign government agencies. The company sells its products through its direct sales force, distribution channels and distribution partners/agents, online stores, and third-party resellers. Cadre Holdings, Inc. was founded in 1964 and is headquartered in Jacksonville, Florida.
FAQ
Is CDRE financially healthy?
Cadre Holdings, Inc.'s Piotroski F-score is 6/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does CDRE pay a dividend, and is it safe?
Yes. Cadre Holdings, Inc. pays a dividend yielding about 1.29% with a 35.0% payout ratio, rated “safe” for safety.
How profitable is CDRE?
In FY2025, Cadre Holdings, Inc. had a net margin of 7.2% and a return on equity of 13.9%.
Is CDRE overvalued or undervalued?
Cadre Holdings, Inc. trades at about 33.1× trailing earnings — below its 10-year norm (10-year range 33.3×–143.1×, median 42.8×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for CDRE?
The average Wall-Street price target for Cadre Holdings, Inc. is $46.80, about 38.8% above the recent price, from 5 analysts.
Is CDRE a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Cadre Holdings, Inc.: a Piotroski F-score of 6/9, an Altman Z″ in the safe zone, a P/E of about 27.2×, a dividend yield of 1.29%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.